Scientists test Last-Line antibiotic against 'Superbug'
NCT ID NCT07369518
Summary
This study aims to understand how well the antibiotic ceftazidime-avibactam works against a dangerous, drug-resistant bacteria called Klebsiella pneumoniae. Researchers will collect samples from 100 hospital patients with infections and test the bacteria in the lab. The main goal is to see if this antibiotic can kill these hard-to-treat bacteria and to learn more about their resistance genes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOLATION OF KLEB. BY CULTURE ON MACCONKEY AGAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of medicine Sohag University
Sohag, Egypt
Conditions
Explore the condition pages connected to this study.